Hepatitis C virus (HCV) infection and liver-related mortality: a population-based cohort study in southern Italy
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Hepatitis C virus (HCV) is a common cause of chronic liver diseases but the degree to which these diseases contribute to liver-related mortality is not well established. The aim of this study was to estimate the absolute and relative effects of HCV infection on liver-related mortality. METHODS: A population random sample of 2472 subjects aged > or = 30 years was enrolled and followed up from 1985 to 1996. At enrollment, a structured interview and a clinical evaluation were performed. Serum samples were tested using HCV ELISA and RIBA HCV. Outcomes were overall and liver-related mortality and tracing procedures included review of office and hospital records, death certificates, and interviews with general practitioners, attending hospital and next of kin. Statistical analysis was performed using Poisson and binomial prospective data regression. RESULTS: Crude overall and liver-related mortality rates were 7.66 (95% CI : 6.68-8.79) and 0.9 (95% CI : 0.3-2.2) per 10(3) person-years, respectively. For HCV infection effect, incidence rate ratio and difference (per 10(3) person-year), risk ratio and difference were 27.5 (95% CI : 6.5-115.6), 4 (95% CI : 3-7), 33.1 (95% CI : 7.8- 139.3) and 0.06 (95% CI : 0.04-0.08), respectively; all measures were adjusted for age at death, sex and daily alcohol intake. CONCLUSIONS: The results show a strong relative but weak absolute effect of HCV infection on liver-related mortality in the 10-year period considered. Poisson and binomial models are virtually equivalent, but the choice of the summarizing measure of effect may have a different impact on health policy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sick individuals and sick populations
ROSE, G. (1985) · International Journal of Epidemiology · doi:10.1093/ije/14.1.32 · Cited by 2,701
ROTHMAN, K. J. (1976) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112335 · Cited by 776
Drinking habits as cofactors of risk for alcohol induced liver damage
Bellentani, S., Saccoccio, G., Costa, G., Tiribelli, C., Manenti, F., Sodde, M., Croce’, L. S., Sasso, F., Pozzato, G., Cristianini, G., et al. (1997) · Gut · doi:10.1136/gut.41.6.845 · Cited by 630
Research works printed but not linked: 42
- 1 Alter MJ. Epidemiology of hepatitis C. Hepatology1997;26:62S–65S. · DOI · Paper page
- Di Bisceglie AM, Goodman ZD, Ishak KG, Hoofnagle JH, Melpolder JJ Alter HJ. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. Hepatology1991;14:969–74. · DOI · Paper page
- Tremolada F, Casarin C, Alberti A et al. Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis. J Hepatol1992;16: 273–81. · DOI · Paper page
- Seef LB, Buskell-Bales Z, Wright EC et al. Long-term mortality after transfusion-associated non-A, non-B hepatitis. N Engl J Med1992; 327:1906–11. · DOI · Paper page
- Koretz RL, Abbey H, Coleman E, Gitnick G. Non-A, non-B post-transfusion hepatitis-looking back in the second decade. Ann Intern Med1993;119:110–15. · DOI · Paper page
- 6 Kao J-H, Tsai S-L, Chen P-J et al. A clinicopathologic study on chronic non-A, non-B (type C) hepatitis in Taiwan: comparison between posttransfusion and sporadic patients. J Hepatol1994;21:244–49. · DOI
- Sanchez-Tapias JM, Lo Iacono O. Storia naturale dell'infezione cronica da HCV: dall'epatite cronica alla cirrosi. In: Craxì A, Almasio P, Magrin S (eds). Il Virus dell'epatite C (HCV): l'infezione e la malattia. Vol. 2. Milano: Roche, 1995, pp.11–25.
- Wejstal R, Hermodsson S, Norkrans G. Long-term follow-up of chronic hepatitis non-A, non-B-with special reference to hepatitis C. Liver1991;11:143–48. · DOI
- Yousuf M, Nakano Y, Tanaka E, Sodeyama T, Kiyosawa K. Persistence of viremia in patients with type-C chronic hepatitis during long-term follow-up. Scand J Gastroenterol1992;27:812–16. · DOI
- Takano S, Yokosuka O, Imazeki F, Tagawa M, Omata M. Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients. Hepatology1995;21:650–55. · DOI · Paper page
- Seef LB and the NHBLI group. Mortality and morbidity of transfusion associated type C hepatitis: an NHLBI multi center study. Hepatology1994;20:204A.
- Adagnino V, Stroffolini T, Rapicetta C et al. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community based survey in Southern Italy. Hepatology1997;26:1006–11 · DOI · Paper page
- Kuboki M, Shinzawa H, Shao L et al. A cohort study of hepatitis C virus (HCV) infection in an HCV epidemic area of Japan: age and sex-related seroprevalence of anti-HCV antibody. Frequency of viremia, biochemical abnormality and histological changes. Liver1999;19:88–96. · DOI
- Osella AR, Misciagna G, Leone A, Di Leo A, Fiore G. Epidemiology of hepatitis C virus infection in an area of southern Italy. J Hepatol1997;27:30–35. · DOI
- Poynar T, Marcellin P, Lee SS et al. Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. Lancet1998;352:1426–32. · DOI · Paper page
- Breslow NE, Storer BE. General relative risk functions for case-control studies. Am J Epidemiol1985;122:149–62. · DOI
- Breslow NE. Use of the power transform to discriminate between additive and multiplicative models in epidemiologic research. In: Moolgavkar SH, Prentice RL (eds). Modern Statistical Methods in Chronic Disease Epidemiology. New York, NY: John Wiley & Sons, 1986, pp.181–96.
- Wacholder S. Binomial regression in GLIM: estimating risk ratios and risk differences. Am J Epidemiol1986;123:174–84. · DOI · Paper page
- Misciagna G, Leoci C, Elba S et al. The epidemiology of cholelithiasis in southern Italy. Eur J Gastroenterol Hepatol1994;6:937–41. · doi:10.1097/00042737-199410000-00017
- Misciagna G, Centonze S, Leoci C et al. Diet, physical activity, and gallstones—a population-based, case-control study in southern Italy. Am J Clin Nutr1999;69:120–26. · DOI · Paper page
- Silini EM, Bono F, Cividini A et al. Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. Hepatology1995;21:285–90. · DOI · Paper page
- Okamoto H, Sugiyama Y, Okada S et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol1992;73:673–79. · DOI · Paper page
- Russo, F, Cavallini A, Messa C et al. Endogenous sex hormones and cholesterol gallstones: a case-control study in an echographic survey of gallstones. Am J Gastroenterol1993;88:712–17.
- Bellentani S, Tiribelli C, Saccoccio G et al. Prevalence of chronic liver disease in the general population of Northern Italy: The Dionysos Study. Hepatology1994;20:1442–49. · DOI · Paper page
- Pagliaro L, Rinaldi F, Craxì A et al. Percutaneous blind biopsy versus laparoscopy with guided biopsy in diagnosis of cirrhosis. Dig Dis Sci1983;28:39–43. · DOI · Paper page
- Colombo M. Hepatocellular carcinoma in cirrhotics. Semin Liver Dis1993;13:374–83. · doi:10.1055/s-2007-1007366
- Ludwig J. The nomenclature of chronic active hepatitis: an obituary. Gastroenterology1993;105:274–78. · DOI · Paper page
- Frome EL. The analysis of rates using Poisson regression models. Biometrics1983;39:665–74. · DOI · Paper page
- Frome EL, Checkoway H. Use of Poisson regression models in estimating incidence rates and ratios. Am J Epidemiol1985;121:309–23. · DOI · Paper page
- Macaluso M. Exact stratification of person-years. Epidemiology1992; 3:441–48. · doi:10.1097/00001648-199209000-00010
- Capocaccia R, Farchi G. Mortality from liver cirrhosis in Italy: proportion associated with consumption of alcohol. J Clin Epidemiol1988;41:347–57. · doi:10.1016/0895-4356(88)90142-4
- GLIM system, Release 3.77. Oxford, England: The Numerical Algorithms Group, 1985.
- Schatzkin A, Slud E. Competing risks bias arising from an omitted risk factor. Am J Epidemiol1989;129:850–56. · doi:10.1093/oxfordjournals.aje.a115199
- Johnson RJ, Gretch DR, Yamabe H et al. Membranoproliferative glomerulonephritis associated with Hepatitis C virus infection. N Engl J Med1993;328:465–70. · DOI · Paper page
- De Bac C, Stroffolini T, Gaeta GB, Taliani G, Giusti G. Pathogenic factors in cirrhosis with and without hepatocellular carcinoma: a multicenter study. Hepatology1994;20:1225–30. · DOI · Paper page
- Rothman KJ, Greenland S (eds). Modern Epidemiology. 2nd Edn. Philadelpia: Lippincott-Raven 1998.
- Pagliaro L, Peri V, Linea C, Cammà C, Giunta M, Magrin S. Natural history of chronic hepatitis C. Ital J Gastroenterol Hepatol1999;31: 28–44.
- Layde PM, Broste SK, Desbiens N et al. Generalizability of clinical studies conducted at tertiary care medical centers: a population-based analysis. J Clin Epidemiol1996;49:835–41. · DOI
- Osella AR, Sonzogni L, Cavallini A et al. Molecular epidemiology of hepatitis C virus infection in an area of hyperendemicity in Southern Italy: a population-based study. J Clin Microbiol1999;37:2371–72. · DOI
- Greenland S, Robins J. Conceptual problems in the definition and interpretation of attributable fractions. Am J Epidemiol1988;128: 1185–97. · DOI · Paper page
- Mangia A, Schiavone G, Lezzi G et al. HCV and diabetes mellitus: evidence for a negative association. Am J Gastroenterol1998;93: 2363–67. · DOI
- Maggi G, Bottelli R, Gola D et al. Serum cholesterol and chronic hepatitis C. Ital J Gastroenterol1996;28:436–40.
Cited by
Vandenbroucke, J. P., von Elm, E., Altman, D. G., Gøtzsche, P. C., Mulrow, C. D., Pocock, S. J., Poole, C., Schlesselman, J. J., Egger, M., & Initiative, F. T. S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040297 · Cited by 8,613
Vandenbroucke, J. P., Elm, E. V., Altman, D. G., Gøtzsche, P. C., Mulrow, C. D., Pocock, S. J., Poole, C., Schlesselman, J. J., Egger, M., & initiative, F. T. S. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-8-200710160-00010-w1 · Cited by 3,543
Vandenbroucke, J. P., von Elm, E., Altman, D. G., Gøtzsche, P. C., Mulrow, C. D., Pocock, S. J., Poole, C., Schlesselman, J. J., & Egger, M. (2014) · International Journal of Surgery · doi:10.1016/j.ijsu.2014.07.014 · Cited by 2,969
Vandenbroucke, J. P., von Elm, E., Altman, D. G., Gøtzsche, P. C., Mulrow, C. D., Pocock, S. J., Poole, C., Schlesselman, J. J., & Egger, M. (2007) · Epidemiology · doi:10.1097/ede.0b013e3181577511 · Cited by 2,779
Amin, J., Law, M. G., Bartlett, M., Kaldor, J. M., & Dore, G. J. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69374-4 · Cited by 267
Tanaka, H., Tsukuma, H., Yamano, H., Oshima, A., & Shibata, H. (2004) · International Journal of Cancer · doi:10.1002/ijc.20507 · Cited by 57
Metadata
- Authors
- Osella, A. R., Misciagna, G., Guerra, V. M., Chiloiro, M., Cuppone, R., Cavallini, A., & Di Leo, A.
- Venue
- International Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-10
- Volume
- 29
- Issue
- 5
- Pages
- 922-927
- ISSN
- 0300-5771 (ISSN-L)
- 1464-3685
- OpenAlex
- W2150391556
- Cited by
- 41
- References
- 3
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.